137 related articles for article (PubMed ID: 9715405)
1. Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma.
Mori S; Aoyagi Y; Yanagi M; Suzuki Y; Asakura H
J Gastroenterol Hepatol; 1998 Jun; 13(6):610-9. PubMed ID: 9715405
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein-producing renal cell carcinoma with increased activity of N-acetylglucosaminyl-transferase III.
Aoyagi Y; Mori S; Naitoh A; Yanagi M; Suzuki Y; Suda T; Isokawa O; Igarashi H; Takahashi T; Isemura M; Asakura H
Nephron; 1996; 74(2):409-14. PubMed ID: 8893165
[TBL] [Abstract][Full Text] [Related]
3. N-acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients.
Ishibashi K; Nishikawa A; Hayashi N; Kasahara A; Sato N; Fujii S; Kamada T; Taniguchi N
Clin Chim Acta; 1989 Dec; 185(3):325-32. PubMed ID: 2482796
[TBL] [Abstract][Full Text] [Related]
4. N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma.
Yanagi M; Aoyagi Y; Suda T; Mita Y; Asakura H
J Gastroenterol Hepatol; 2001 Nov; 16(11):1282-9. PubMed ID: 11903748
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma.
Fujiyama S; Izuno K; Gohshi K; Shibata J; Sato T
Dig Dis Sci; 1991 Dec; 36(12):1787-92. PubMed ID: 1721019
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of the assay of des-gamma-carboxy prothrombin in the detection of small hepatocellular carcinoma.
Chan CY; Lee SD; Wu JC; Lin HC; Huang YS; Lo GH; Lee FY; Tsai YT; Lo KJ
J Hepatol; 1991 Jul; 13(1):21-4. PubMed ID: 1717542
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
[TBL] [Abstract][Full Text] [Related]
8. Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
Shimada M; Takenaka K; Fujiwara Y; Gion T; Kajiyama K; Maeda T; Shirabe K; Sugimachi K
Cancer; 1996 Nov; 78(10):2094-100. PubMed ID: 8918402
[TBL] [Abstract][Full Text] [Related]
9. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
11. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
12. Determination of UDP-N-acetylglucosamine: beta-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody.
Song EY; Kim KS; Kim KA; Kim YD; Kwon DH; Byun SM; Kim HJ; Chung TW; Choe YK; Chung TW; Kim CH
Glycoconj J; 2002 Jul; 19(6):415-21. PubMed ID: 14707488
[TBL] [Abstract][Full Text] [Related]
13. Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Mita Y; Aoyagi Y; Suda T; Asakura H
J Hepatol; 2000 Jun; 32(6):946-54. PubMed ID: 10898315
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Cerban R; Ester C; Iacob S; Paslaru L; Dumitru R; Grasu M; Constantin G; Popescu I; Gheorghe L
Chirurgia (Bucur); 2018; 113(4):524-533. PubMed ID: 30183583
[TBL] [Abstract][Full Text] [Related]
15. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma.
Suzuki Y; Aoyagi Y; Mori S; Suda T; Naitoh A; Isokawa O; Yanagi M; Igarashi H; Asakura H
J Gastroenterol Hepatol; 1996 Apr; 11(4):358-65. PubMed ID: 8713703
[TBL] [Abstract][Full Text] [Related]
16. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
18. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.
Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H
Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283
[TBL] [Abstract][Full Text] [Related]
20. Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.
Aoyagi Y; Suzuki Y; Isemura M; Soga K; Ozaki T; Ichida T; Inoue K; Sasaki H; Ichida F
Gan; 1984 Sep; 75(9):809-15. PubMed ID: 6209189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
